Gateway Health Alliances (GHA) Enforcement Actions Taken

FAIRFIELD, Calif., Feb 24, 2012 (GlobeNewswire via COMTEX) — Gateway Health Alliances, Inc. (“GHA”) has launched a comprehensive patent and trademark enforcement campaign targeting infringers who provide knock off products in the nutritional supplement market. GHA owns U.S. Patent No. 7,537,790 as well as various U.S. and foreign pending patent applications, registered trademarks, and trade secrets covering and involving Irvingia gabonensis (African Mango) and it’s extracts, including IGOB131(R).

Dr. Oz referred to the African mango product in an interview as a “miracle in your medicine cabinet that will help you lose 10 pounds” and labeled it one of his “breakthrough fixes for women over 40.” This product is based on GHA’s proprietary extract Irvingia IGOB131(R), a unique proprietary ingredient whose efficacy and safety has been proven through peer reviewed clinical research and protected by issued and pending U.S. patents and trademarks. Unfortunately, several companies are selling untested ingredients (not the tested and clinically proven IGOB131(R) ingredient).

Patent and Trademark counsel for GHA, Steve Hassid (Partner at Silicon Edge Law Group, LLP, 310-634-1717) stated, “We recently started an ongoing IP enforcement campaign for my client, GHA. Knock-off infringers who try to improperly benefit from my client’s research, intellectual property and good will, will be stopped. As a result of their ongoing enforcement campaign, drug-mass-grocery retail, health food retail, online and nutraceutical companies have already pulled infringing and potentially unsafe products from their shelves and on-line stores and licensed the technology and/or purchased licensed IGOB131(R) ingredients from my client. Since the campaign started, numerous parties have contacted me and my client requesting a voluntarily license of GHA’s technology to avoid legal action.”

GHA’s efforts are consistent with the natural products industries effort to rid its channels of fraudulent products making false claims on raw material that is not consistent with the science that supports the structure function claims and the safety of the ingredient. Irvingia IGOB131(R) – the weight loss ingredient backed by clinical research.

Subscribe to get the latest news